175 related articles for article (PubMed ID: 34865514)
1. FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure.
Sommakia S; Almaw NH; Lee SH; Ramadurai DKA; Taleb I; Kyriakopoulos CP; Stubben CJ; Ling J; Campbell RA; Alharethi RA; Caine WT; Navankasattusas S; Hoareau GL; Abraham AE; Fang JC; Selzman CH; Drakos SG; Chaudhuri D
Circ Heart Fail; 2022 Mar; 15(3):e008910. PubMed ID: 34865514
[TBL] [Abstract][Full Text] [Related]
2. Elevated Serum Fibroblast Growth Factor 21 Is Relevant to Heart Failure Patients with Reduced Ejection Fraction.
Fan L; Gu L; Yao Y; Ma G
Comput Math Methods Med; 2022; 2022():7138776. PubMed ID: 35069790
[TBL] [Abstract][Full Text] [Related]
3. Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction.
Chou RH; Huang PH; Hsu CY; Chang CC; Leu HB; Huang CC; Chen JW; Lin SJ
Sci Rep; 2016 Sep; 6():33953. PubMed ID: 27650781
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy.
Gu L; Jiang W; Zheng R; Yao Y; Ma G
Cardiology; 2021; 146(1):27-33. PubMed ID: 33264784
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21 in heart failure.
Tucker W; Tucker B; Rye KA; Ong KL
Heart Fail Rev; 2023 Jan; 28(1):261-272. PubMed ID: 36028609
[TBL] [Abstract][Full Text] [Related]
6. Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death.
Shen Y; Zhang X; Pan X; Xu Y; Xiong Q; Lu Z; Ma X; Bao Y; Jia W
Cardiovasc Diabetol; 2017 Aug; 16(1):106. PubMed ID: 28821258
[TBL] [Abstract][Full Text] [Related]
7. The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis.
Tucker W; McClelland RL; Allison MA; Szklo M; Rye KA; Ong KL
Metabolism; 2023 Jun; 143():155535. PubMed ID: 36931558
[TBL] [Abstract][Full Text] [Related]
8. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
[TBL] [Abstract][Full Text] [Related]
9. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
10. Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure.
Andersen IA; Huntley BK; Sandberg SS; Heublein DM; Burnett JC
Nephrol Dial Transplant; 2016 May; 31(5):767-72. PubMed ID: 26666498
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
[TBL] [Abstract][Full Text] [Related]
12. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
14. Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.
Okamoto Y; Fujita S; Morita H; Kizawa S; Ito T; Sakane K; Sohmiya K; Hoshiga M; Ishizaka N
Heart Vessels; 2016 Jan; 31(1):66-73. PubMed ID: 25223536
[TBL] [Abstract][Full Text] [Related]
15. DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism.
Furukawa N; Koitabashi N; Matsui H; Sunaga H; Umbarawan Y; Syamsunarno MRAA; Yamaguchi A; Obokata M; Hanaoka H; Yokoyama T; Kurabayashi M
Heart Vessels; 2021 Jan; 36(1):136-146. PubMed ID: 33073318
[TBL] [Abstract][Full Text] [Related]
16. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
17. The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
Ferrer-Curriu G; Guitart-Mampel M; Rupérez C; Zamora M; Crispi F; Villarroya F; Fernández-Solà J; Garrabou G; Planavila A
J Pathol; 2021 Feb; 253(2):198-208. PubMed ID: 33125701
[TBL] [Abstract][Full Text] [Related]
18. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
Ichiki T; Schirger JA; Huntley BK; Brozovich FV; Maleszewski JJ; Sandberg SM; Sangaralingham SJ; Park SJ; Burnett JC
J Mol Cell Cardiol; 2014 Oct; 75():199-205. PubMed ID: 25117468
[TBL] [Abstract][Full Text] [Related]
19. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
